Alzheimer's Dementia from Speech

Alzheimer’s dementia (AD) is a chronic neurodegenerative illness that manifests in a gradual decline of cognitive function. Early identification of AD is essential for managing the ensuing cognitive deficits, which may lead to a better prognostic outcome. Speech data can serve as a window into cognitive functioning and can be used to screen for early signs of AD. This paper describes methods for learning models using speech samples from the DementiaBank database, for identifying which subjects have Alzheimer’s dementia. We consider two machine learning tasks:

(a)~binary classification to distinguish patients from healthy controls, and

(b)~regression to estimate each subject’s Mini-Mental State Examination (MMSE) score.

To develop models that can use acoustic and/or language features, we explore a variety of dimension reduction techniques, training algorithms, and fusion strategies. Our best performing classification model, using language features with dimension reduction and regularized logistic regression, achieves an accuracy of 85.4\% on a held-out test set. On the regression task, a linear regression model trained on a reduced set of language features achieves an RMSE of 5.62 on the test set.

These results demonstrate the promise of using machine learning for detecting cognitive decline from speech in AD patients.

How we work:

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact:
Nimmi Anna
Journal Manager
Allied Journal of Medical Research
Email: medicalresearch@emedsci.com
https://www.alliedacademies.org/allied-journal-of-medical-research/